EZH2 and ovarian cancer: Importantly, the results of ChIP assay showed that EZH2 could bind to P21 promoter region, and knockdown of LINC00511 expression could decrease EZH2’s binding to P21 promoter region and H3K27me3 modification in ovarian cancer cell (Figure 5F).